Brevan Howard Capital Management LP Biocryst Pharmaceuticals Inc Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 54,022 shares of BCRX stock, worth $521,852. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,022
Previous 56,644
4.63%
Holding current value
$521,852
Previous $425,000
4.71%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BCRX
# of Institutions
293Shares Held
177MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$209 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$193 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$86.2 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$84 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$75.5 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.8B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...